164 related articles for article (PubMed ID: 33807401)
1. Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate.
Islam MS; Renner F; Foster K; Oderinde MS; Stefanski K; Mitra S
Molecules; 2021 Mar; 26(7):. PubMed ID: 33807401
[TBL] [Abstract][Full Text] [Related]
2. Enhanced aqueous dissolution of hydrophobic apixaban via direct incorporation of hydrophilic nanographene oxide.
Islam MS; Renner F; Foster K; Oderinde MS; Stefanski K; Mitra S
Colloids Surf B Biointerfaces; 2022 Aug; 216():112512. PubMed ID: 35533561
[TBL] [Abstract][Full Text] [Related]
3. Direct incorporation of nano graphene oxide (nGO) into hydrophobic drug crystals for enhanced aqueous dissolution.
Islam MS; Renner F; Azizighannad S; Mitra S
Colloids Surf B Biointerfaces; 2020 May; 189():110827. PubMed ID: 32028132
[TBL] [Abstract][Full Text] [Related]
4. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
5. Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability.
Hong SW; Lee BS; Park SJ; Jeon HR; Moon KY; Kang MH; Park SH; Choi SU; Song WH; Lee J; Choi YW
Arch Pharm Res; 2011 Jan; 34(1):127-35. PubMed ID: 21468924
[TBL] [Abstract][Full Text] [Related]
6. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of Eudragit polymeric nanoparticles using ultrasonic nebulization method for enhanced oral absorption of megestrol acetate.
Seo YD; Jin SE; Kim D; Lee DH; Yang SG
Pharm Dev Technol; 2018 Apr; 23(4):407-413. PubMed ID: 29095656
[TBL] [Abstract][Full Text] [Related]
8. Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state.
Jang K; Yoon S; Kim SE; Cho JY; Yoon SH; Lim KS; Yu KS; Jang IJ; Lee H
Drug Des Devel Ther; 2014; 8():851-8. PubMed ID: 25028536
[TBL] [Abstract][Full Text] [Related]
9. Nanonization of megestrol acetate by laser fragmentation in aqueous milieu.
Sylvestre JP; Tang MC; Furtos A; Leclair G; Meunier M; Leroux JC
J Control Release; 2011 Feb; 149(3):273-80. PubMed ID: 21047539
[TBL] [Abstract][Full Text] [Related]
10. The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro-in vivo correlation of nanocrystals.
Imono M; Uchiyama H; Yoshida S; Miyazaki S; Tamura N; Tsutsumimoto H; Kadota K; Tozuka Y
Eur J Pharm Biopharm; 2020 Jan; 146():84-92. PubMed ID: 31816392
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
[TBL] [Abstract][Full Text] [Related]
12. Microwave Synthesis of Nanostructured Functionalized Polylactic Acid (nfPLA) for Incorporation Into a Drug Crystals to Enhance Their Dissolution.
Islam MS; Mitra S
J Pharm Sci; 2023 Aug; 112(8):2260-2266. PubMed ID: 36958690
[TBL] [Abstract][Full Text] [Related]
13. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid.
Piao ZZ; Choe JS; Oh KT; Rhee YS; Lee BJ
Eur J Pharm Sci; 2014 Jan; 51():67-74. PubMed ID: 24012590
[TBL] [Abstract][Full Text] [Related]
15. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
Badawy MA; Kamel AO; Sammour OA
Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
17. Excipient-assisted vinpocetine nanoparticles: experiments and molecular dynamic simulations.
Li CX; Wang HB; Oppong D; Wang JX; Chen JF; Le Y
Mol Pharm; 2014 Nov; 11(11):4023-35. PubMed ID: 25244002
[TBL] [Abstract][Full Text] [Related]
18. Controlled precipitation for enhanced dissolution rate of flurbiprofen: development of rapidly disintegrating tablets.
Essa EA; Elmarakby AO; Donia AMA; El Maghraby GM
Drug Dev Ind Pharm; 2017 Sep; 43(9):1430-1439. PubMed ID: 28402193
[TBL] [Abstract][Full Text] [Related]
19. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Optimization of PEGylated Nano Graphene Oxide-Based Delivery System for Drugs with Different Molecular Structures Using Design of Experiment (DoE).
Shariare MH; Masum AA; Alshehri S; Alanazi FK; Uddin J; Kazi M
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
